Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PGI2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Douma, CE; de Waart, DR; Zemel, D; Struijk, DG; Krediet, RT
      Prostaglandin inhibition by intraperitoneal indomethacin on peritoneal permeability during stable CAPD

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    2. Sorbera, LA; Rabasseda, X; Castaner, J
      UT-15 - Treatment of pulmonary hypertension, treatment of peripheral vascular disease

      DRUGS OF THE FUTURE
    3. Lee, NH; Larock, RC
      Efficient synthesis of benzoprostacyclins using free-radical and palladium-catalyzed tandem alkene insertion strategies

      BULLETIN OF THE KOREAN CHEMICAL SOCIETY
    4. Imanishi, M; Tsuji, T; Nakamura, S; Takamiya, M
      Prostaglandin I-2/E-2 ratios in unilateral renovascular hypertension of different severities

      HYPERTENSION
    5. Abe, Y; Tatsumi, K; Sugito, K; Ikeda, Y; Kimura, H; Kuriyama, T
      Effects of inhaled prostacyclin analogue on chronic hypoxic pulmonary hypertension

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    6. Tran, HS; Quinn, JV; Puc, MM; Woolley, DS; Puglisi, RN; Slotman, GJ
      Prostacyclin is neither sufficient alone nor necessary to cause pulmonary dysfunction: Results from infusions of prostacyclin and antiprostacyclin antibody in porcine septic shock

      CRITICAL CARE MEDICINE
    7. Spisni, E; Griffoni, C; Santi, S; Riccio, M; Marulli, R; Bartolini, G; Toni, M; Ullrich, V; Tomasi, V
      Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis

      EXPERIMENTAL CELL RESEARCH
    8. Rimensberger, PC; Spahr-Schopfer, I; Berner, M; Jaeggi, E; Kalangos, A; Friedli, B; Beghetti, M
      Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease - Vasodilator capacityand cellular mechanisms

      CIRCULATION
    9. Wakita, H; Yoshiwara, H; Kitano, Y; Nishiyama, H; Nagase, H
      Preparative resolution of 2-methyl-4-hexynic acid for the synthesis of optically active m-phenylene PGI(2) derivatives and determination of their absolute configuration

      TETRAHEDRON-ASYMMETRY
    10. Tanaka, H; Tajimi, K; Miyajima, Y; Kazama, M; Kobayashi, K
      Effects of milrinone on platelet aggregation in swine with pulmonary hypertension

      JOURNAL OF CRITICAL CARE
    11. Wakita, H; Yoshiwara, H; Nishiyama, H; Nagase, H
      Total synthesis of optically active m-phenylene PGI(2) derivative: Beraprost

      HETEROCYCLES
    12. Wang, SS; Chu, CJ; Lee, FY; Wu, SL; Lin, HC; Chan, CC; Chang, FY; Lee, SD
      Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    13. Badesch, DB; Tapson, VF; McGoon, MD; Brundage, BH; Rubin, LJ; Wigley, FM; Rich, S; Barst, RJ; Barrett, PS; Kral, KM; Jobsis, MM; Loyd, JE; Murali, S; Frost, A; Girgis, R; Bourge, RC; Ralph, DD; Elliott, CG; Hill, NS; Langleben, D; Schilz, RJ; McLaughlin, VV; Robbins, IM; Groves, BM; Shapiro, S; Medsger, TA; Gaine, SP; Horn, E; Decker, JC; Knobil, K
      Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial

      ANNALS OF INTERNAL MEDICINE
    14. Wakita, H; Yoshiwara, H; Tajima, A; Kitano, Y; Nagase, H
      Preparative resolution of a key intermediate for the synthesis of optically active m-phenylene PGI(2) derivatives

      TETRAHEDRON-ASYMMETRY
    15. Wakita, H; Matsumoto, K; Yoshiwara, H; Hosono, Y; Hayashi, R; Nishiyama, H; Nagase, H
      Synthesis of 5,6,7-trinor-4,8-inter-m-phenylene PGI(2) and Beraprost

      TETRAHEDRON
    16. Ikeda, S; Shirai, M; Shimouchi, A; Min, KY; Ohsawa, N; Ninomiya, I
      Pulmonary microvascular responses to inhaled prostacyclin, nitric oxide, and their combination in anesthetized cats

      JAPANESE JOURNAL OF PHYSIOLOGY
    17. Guazzi, M; Pontone, G; Agostoni, P
      Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors

      AMERICAN HEART JOURNAL
    18. MINK SN; BECKER A; UNRUH H; KEPRON W
      EFFECTS OF ANAPHYLAXIS MEDIATORS ON PARTITIONED PULMONARY VASCULAR-RESISTANCE DURING RAGWEED SHOCK IN DOGS

      Journal of applied physiology
    19. TOTSUKA E; TODO S; ZHU Y; ISHIZAKI N; KAWASHIMA Y; JIN MB; URAKAMI A; SHIMAMURA T; STARZL TE
      ATTENUATION OF ISCHEMIC LIVER-INJURY BY PROSTAGLANDIN E-1 ANALOG, MISOPROSTOL, AND PROSTAGLANDIN I-2 ANALOG, OP-41483

      Journal of the American College of Surgeons
    20. NISHIYAMA H; SAKATA N; SUGIMOTO H; MOTOYAMA Y; WAKITA H; NAGASE H
      SYNTHESIS OF OPTICALLY-ACTIVE CYCLOPENTA[B]BENZOFURAN AS A PRECURSOR OF M-PHENYLENEPROSTACYCLIN

      Synlett
    21. Wakita, H; Hosono, Y; Nagase, H
      Regioselective protection of 11-hydroxy group and inversion of configuration at C-15 in m-phenylene PGI(2) derivatives

      HETEROCYCLES
    22. ATTAR A; TUNA H; SARGON MF; YUCEER N; TURKER RK; EGEMEN N
      EARLY PROTECTIVE EFFECTS OF ILOPROST AFTER EXPERIMENTAL SPINAL-CORD INJURY

      Neurological research
    23. BOUAZIZ A; DEFICQUELMONTLOIZOS MM; RICHERT A; CAPRANI A
      DIRECT PHYSICAL FACTORS AND PGI2 AND TXA2 SECRETIONS BY A HUMAN ENDOTHELIAL-CELL LINE - IN-VITRO INVESTIGATION OF PRESSURE AND SHEAR-STRESSAPPLIED INDEPENDENTLY OR IN SYNERGY

      Thrombosis research
    24. LINDSTROM T; GULLICHSEN E; RIUTTA A
      THE EFFECT OR UNREAMED AND REAMED INTRAMEDULLARY NAILING ON THE URINARY-EXCRETION OF PROSTACYCLIN AND THROMBOXANE A(2) METABOLITES IN PATIENTS WITH TIBIAL SHAFT FRACTURES

      The journal of trauma, injury, infection, and critical care
    25. WEN FQ; WATANABE K; YOSHIDA M
      LIPOPOLYSACCHARIDE AND CYTOKINES ENHANCE BRADYKININ-STIMULATED PRODUCTION OF PGI(2) BY CULTURED HUMAN PULMONARY-ARTERY SMOOTH-MUSCLE CELLS

      Cell biology international
    26. NISHIYAMA H; SAKATA N; MOTOYAMA Y; WAKITA H; NAGASE H
      ASYMMETRIC INDUCTION IN INTRAMOLECULAR S(N)2' REACTION - ENANTIOSELECTIVE SYNTHESIS OF CYCLOPENTA[B]BENZOFURAN WITH CHIRAL LITHIUM ALKOXIDES

      Synlett
    27. ROMAO JE; FADIL MA; SABBAGA E; MARCONDES M
      HEMODIALYSIS WITHOUT ANTICOAGULANT - HEMOSTASIS PARAMETERS, FIBRINOGEN KINETIC, AND DIALYSIS EFFICIENCY

      Nephrology, dialysis, transplantation
    28. NIELSEN CB; BECH JN; PEDERSEN EB
      EFFECTS OF PROSTACYCLIN ON RENAL HEMODYNAMICS, RENAL TUBULAR FUNCTIONAND VASOACTIVE HORMONES IN HEALTHY HUMANS - A PLACEBO-CONTROLLED DOSE-RESPONSE STUDY

      British journal of clinical pharmacology
    29. KURATA M; TANAKA K; USAMI M
      DIFFERENT ROLES OF ENDOTHELIUM-DERIVED SUBSTANCES ON INHIBITING PLATELET-AGGREGATION IN WHOLE-BLOOD

      General pharmacology
    30. MEGGIATO C; PADOIN E; RAGAZZI E; CHINELLATO A; DONI MG
      INHIBITION OF PLATELET ACTIVATION BY MM-706, A STABLE CARBACYCLIN ANALOG, IN THE CONSCIOUS RAT

      General pharmacology
    31. BATTAL MN; HATA Y; MATSUKA K; ITO O; MATSUDA H; YOSHIDA Y; KAWAZOE T; NAGAO M
      EFFECT OF A PROSTAGLANDIN I-2 ANALOG, BERAPROST SODIUM, ON BURN-INDUCED GASTRIC-MUCOSAL INJURY IN RATS

      Burns
    32. SCHULZENEICK I; UHLEMANN F; NURNBERG JH; BULTMANN M; HAAS NA; DAHNERT I; ALEXIMESHKISHVILI V; OPITZ C; PAPPERT D; ROSSAINT R; KLEBER FX; HETZER R; LANGE PE
      AEROLIZED PROSTACYCLIN FOR PREOPERATIVE E VALUATION AND POSTOPERATIVETREATMENT OF PATIENTS WITH PULMONARY-HYPERTENSION

      Zeitschrift fur Kardiologie
    33. MIKHAIL G; GIBBS JSR; RICHARDSON M; WRIGHT G; KHAGHANI A; BANNER N; YACOUB M
      AN EVALUATION OF NEBULIZED PROSTACYCLIN IN PATIENTS WITH PRIMARY AND SECONDARY PULMONARY-HYPERTENSION

      European heart journal
    34. BOUAZIZ A; RICHERT A; CAPRANI A
      VASCULAR ENDOTHELIAL-CELL RESPONSES TO DIFFERENT ELECTRICALLY CHARGEDPOLY(VINYLIDENE FLUORIDE) SUPPORTS UNDER STATIC AND OSCILLATING FLOW CONDITIONS

      Biomaterials
    35. KANEKO T; NAGAMACHI Y; MATSUZAKI S
      SUPPRESSION OF HISTIDINE-DECARBOXYLASE ACTIVITY IN RAT OXYNTIC MUCOSABY BERAPROST SODIUM, A PROSTACYCLIN ANALOG

      Prostaglandins
    36. NOVACEK G; KAPIOTIS S; JILMA B; QUEHENBERGER P; MICHITSCH A; TRAINDL O; SPEISER W
      ENHANCED BLOOD-COAGULATION AND ENHANCED FIBRINOLYSIS DURING HEMODIALYSIS WITH PROSTACYCLIN

      Thrombosis research
    37. HILDEBRAND M
      PHARMACOKINETICS AND TOLERABILITY OF ORAL ILOPROST IN THROMBOANGIITIS-OBLITERANS PATIENTS

      European Journal of Clinical Pharmacology
    38. NISHIO S; NAGASE H; KANOU K; AOKI S; KANBAYASHI Y
      RESEARCH-AND-DEVELOPMENT OF BERAPROST SOD IUM, A NEW STABLE PGI(2) ANALOG

      Yakugaku zasshi
    39. FORNI LG; HILTON PJ
      CURRENT CONCEPTS - CONTINUOUS HEMOFILTRATION IN THE TREATMENT OF ACUTE-RENAL-FAILURE

      The New England journal of medicine
    40. ZHAO YJ; WANG J; TOD ML; RUBIN LJ; YUAN XJ
      PULMONARY VASOCONSTRICTOR EFFECTS OF PROSTACYCLIN IN RATS - POTENTIALROLE OF THROMBOXANE RECEPTORS

      Journal of applied physiology
    41. CUIPER LL; PRICE PV; CHRISTMAN BW
      SYSTEMIC AND PULMONARY-HYPERTENSION AFTER ABRUPT CESSATION OF PROSTACYCLIN - ROLE OF THROMBOXANE A(2)

      Journal of applied physiology
    42. TERASHITA Z; IMURA Y; NISHIKAWA K
      INHIBITION OF ARACHIDONIC-ACID INDUCED-AGGREGATION OF RABBIT PLATELETS WITH CV-4151 (ISBOGREL), A SELECTIVE THROMBOXANE A(2) (TXA(2)) SYNTHASE INHIBITOR - MODULATION OF THE ANTIPLATELET ACTION AND PROSTANOID METABOLISM BY RAT AORTIC RINGS

      Journal of lipid mediators and cell signalling
    43. LEVINE L
      PROSTACYCLIN PRODUCTION AFTER TREATMENT OF RAT-LIVER CELLS WITH TOSYL-L-PHENYLALANINE CHLOROMETHYL KETONE AND 12-O-TETRADECANOYLPHORBOL-13-ACETATE IS MEDIATED BY A PHORBOL-ESTER-STIMULATED INTERMEDIATE

      Cellular signalling
    44. NAKANO T; MAKINO M; MORIZAWA Y; MATSUMURA Y
      SYNTHESIS OF NOVEL DIFLUOROPROSTACYCLIN DERIVATIVES - UNPRECEDENTED STABILIZING EFFECT OF FLUORINE SUBSTITUENTS

      Angewandte Chemie, International Edition in English
    45. UENO Y; YAMADA N; KOIKE H; NISHIO S
      EFFECTS OF BERAPROST SODIUM AND PROSTAGLANDIN E(1) SKIN BLOOD-FLOW INDIABETIC RATS AND NORMAL DOGS

      General pharmacology
    46. UENO Y; OKAZAKI S; ISOGAYA M; NISHIO S; TANAKA H; KATO Y; SHIGENOBU K
      POSITIVE INOTROPIC AND CHRONOTROPIC EFFECTS OF BERAPROST SODIUM, A STABLE ANALOG OF PROSTACYCLIN, IN ISOLATED GUINEA-PIG MYOCARDIUM

      General pharmacology
    47. BATTAL MN; HATA Y; MATSUKA K; ITO O; MATSUDA H; YOSHIDA Y; KAWAZOE T
      REDUCTION OF PROGRESSIVE BURN INJURY BY A STABLE PROSTAGLANDIN I-2 ANALOG, BERAPROST SODIUM (PROCYLIN) - AN EXPERIMENTAL-STUDY IN RATS

      Burns
    48. ALEXANDROU K; HATA Y; MATSUKA K; MATSUDA H
      EFFECT OF BERAPROST SODIUM (PROCYLIN(TM)), A STABLE PROSTAGLANDIN I-2ANALOG, ON A DORSAL SKIN FLAP MODEL IN RATS

      Scandinavian journal of plastic and reconstructive surgery and hand surgery
    49. CLOSA D; BARDAJI M; HOTTER G; PRATS N; GELPI E; FERNANDEZCRUZ L; ROSELLOCATAFAU J
      HEPATIC INVOLVEMENT IN PANCREATITIS-INDUCED LUNG DAMAGE

      American journal of physiology: Gastrointestinal and liver physiology
    50. POPLAWSKI C; DLUGOSZ JW; GABRYELEWICZ A; PAWLICKA E; WROBLEWSKI E; ANDRZEJEWSKA A
      HEPATIC MITOCHONDRIAL AND LYSOSOMAL ALTERATIONS IN ACUTE EXPERIMENTALPANCREATITIS WITH ETHANOLIC COETIOLOGY IN RATS

      Digestive diseases and sciences
    51. CARLTON LD; PATTERSON JH; MATTSON CN; SCHMITH VD
      THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .1. A PILOT-STUDY OF THE PHARMACOKINETICS OF DIGOXIN WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

      Journal of clinical pharmacology
    52. CARLTON LD; PATTERSON JH; MATTSON CN; SCHMITH VD
      THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .2. A PILOT-STUDY OF THE PHARMACOKINETICS OF FUROSEMIDE WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

      Journal of clinical pharmacology
    53. WU RF; WANG ZH; LU LC; ZHANG FG; GE XL
      RELATIONSHIP BETWEEN PROSTAGLANDIN IN PERITONEAL-FLUID AND PELVIC VENOUS CONGESTION AFTER STERILIZATION

      Prostaglandins
    54. EJIRI S; EGUCHI Y; KISHIDA A; XIE G; KURUMI Y; KODAMA M
      PROTECTIVE EFFECT OF A PROSTAGLANDIN I-2 ANALOG ON GRAFTED LIVERS SUBJECTED TO IN-SITU WARM ISCHEMIA IN PORCINE ORTHOTOPIC LIVER-TRANSPLANTATION - IMMUNOHISTOCHEMICAL ANALYSIS OF THROMBOMODULIN

      Transplantation proceedings
    55. NAGASE H; MATSUMOTO K; NISHIYAMA H
      SYNTHETIC STUDY OF A NEW CLASS OF STABLE PGI(2) ANALOG, M-PHENYLENE PGI(2) - SYNTHESIS OF BERAPROST SODIUM

      Yuki Gosei Kagaku Kyokaishi
    56. BARST RJ; RUBIN LJ; LONG WA; MCGOON MD; RICH S; BADESCH DB; GROVES BM; TAPSON VF; BOURGE RC; BRUNDAGE BH; KOERNER SK; LANGLEBEN D; KELLER CA; MURALI S; URETSKY BF; CLAYTON LM; JOBSIS MM; BLACKBURN SD; SHORTINO D; CROW JW
      A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY-HYPERTENSION

      The New England journal of medicine
    57. DLUGOSZ JW; POPLAWSKI C; PAWLICKA E; WROBLEWSKI E; GABRYELEWICZ A
      THE EFFECT OF TILSUPROST ON THE LIVER-MITOCHONDRIA IN TAUROCHOLATE PANCREATITIS IN RATS WITH ANTECEDENT ACUTE ETHANOL ABUSE

      Life sciences
    58. NELL A; MATEJKA M; SOLAR P; ULM C; SINZINGER H
      EVIDENCE THAT CYCLOSPORINE INHIBITS PERIODONTAL PROSTAGLANDIN I-2 SYNTHESIS

      Journal of Periodontal Research
    59. ZHAO G; XU XB; OCHOA M; SHEN WQ; HINTZE TH
      INTERACTION BETWEEN PROSTACYCLIN AND NITRIC-OXIDE IN THE REFLEX CONTROL OF THE CORONARY CIRCULATION IN CONSCIOUS DOGS

      Cardiovascular Research
    60. NORMAN JF; MILLER CW; ALLEN KGD
      THORACIC AORTA PROSTACYCLIN PRODUCTION IS NOT ALTERED DURING EARLY ATHEROSCLEROSIS DEVELOPMENT IN YOUNG SWINE

      Journal of nutritional biochemistry
    61. MEST HJ; PONICKE K; HEINROTHHOFFMANN I; MEISSNER N; GIESSLER C
      RELEVANCE OF MEDIATORS TO CARDIAC PARAMETERS OF ISOLATED ANAPHYLACTICGUINEA-PIG HEART

      Prostaglandins, leukotrienes and essential fatty acids
    62. MATSUMURA Y; WANG SZ; ASAI T; SHIMADA T; MORIZAWA Y; YASUDA A
      FACILE AND EFFICIENT SYNTHESIS OF FLUOROPROSTACYCLIN ANALOGS

      Synlett
    63. DARIUS H; BINZ C; VEIT K; FISCH A; MEYER J
      PLATELET RECEPTOR DESENSITIZATION INDUCED BY ELEVATED PROSTACYCLIN LEVELS CAUSES PLATELET-ENDOTHELIAL CELL-ADHESION

      Journal of the American College of Cardiology
    64. MATSUMURA K; WATANABE Y; ONOE H; WATANABE Y
      PROSTACYCLIN RECEPTOR IN THE BRAIN AND CENTRAL TERMINALS OF THE PRIMARY SENSORY NEURONS - AN AUTORADIOGRAPHIC STUDY USING A STABLE PROSTACYCLIN ANALOG [H-3] ILOPROST

      Neuroscience
    65. KRITZ H; ULM MR; SINZINGER H
      RADIATION-INDUCED VASCULAR DAMAGE

      VASA
    66. UENO Y; KOIKE H; NISHIO S
      BENEFICIAL-EFFECTS OF BERAPROST SODIUM, A STABLE PROSTACYCLIN ANALOG,IN DIABETIC CARDIOMYOPATHY

      Journal of cardiovascular pharmacology
    67. ISOGAYA M; YAMADA N; KOIKE H; UENO Y; KUMAGAI H; OCHI Y; OKAZAKI S; NISHIO S
      INHIBITION OF RESTENOSIS BY BERAPROST SODIUM (A PROSTAGLANDIN I-2 ANALOG) IN THE ATHEROSCLEROTIC RABBIT ARTERY AFTER ANGIOPLASTY

      Journal of cardiovascular pharmacology
    68. BOUAZIZ A; VACHER M; CAPRANI A
      EFFECT OF CONSTANT AND MODULATED ELECTRICAL CHARGES APPLIED TO THE CULTURE MATERIAL ON PGI2 AND TXA2 SECRETION BY ENDOTHELIAL-CELLS

      Biomaterials
    69. CARLTON LD; SCHMITH VD; BROUWER KLR
      INTRAVENOUS EPOPROSTENOL SODIUM DOES NOT INCREASE HEPATIC-MICROSOMAL ENZYME-ACTIVITY IN RATS

      Prostaglandins
    70. ROSSONI G; BERTI F; BERTI M; BERNAREGGI M; TRENTO F; PORTA R; PESCADOR R; FERRO L
      OLIGOTIDE, A NEW SINGLE-STRANDED OLIGODEOXYRIBONUCLEOTIDE, PRESERVES POSTSYNAPTIC BETA-ADRENERGIC AND CHOLINERGIC RECEPTOR FUNCTIONS IN RABBIT HEARTS AFTER ACUTE INFARCTION

      Thrombosis research
    71. UENO Y; KAWASHIMA A; KOIKE H; NISHIO S
      EFFECT OF BERAPROST SODIUM, A STABLE PROSTACYCLIN ANALOG, ON PULMONARY THROMBOEMBOLISM IN MICE

      Thrombosis research
    72. MATSUMURA Y; SHIMADA T; NAKAYAMA T; URUSHIHARA M; ASAI T; MORIZAWA Y; YASUDA A
      SYNTHESIS OF 7-FLUORO-2,4-METHYLENE-17,20-DIMETHYLPROSTACYCLINS - NOVEL STABLE PROSTACYCLIN ANALOGS AS POTENT ANTIANGINAL AGENTS

      Tetrahedron
    73. KANAI N; LU R; SATRIANO JA; BAO Y; WOLKOFF AW; SCHUSTER VL
      IDENTIFICATION AND CHARACTERIZATION OF A PROSTAGLANDIN TRANSPORTER

      Science
    74. ZOBEL G; DACAR D; RODL S; FRIEHS I
      INHALED NITRIC-OXIDE VERSUS INHALED PROSTACYCLIN AND INTRAVENOUS VERSUS INHALED PROSTACYLIN IN ACUTE RESPIRATORY-FAILURE WITH PULMONARY-HYPERTENSION IN PIGLETS

      Pediatric research
    75. GRIMEE R; WULFERT E
      ACUTE STRESS IN RATS PRODUCES A RAPID AND SUSTAINED INCREASE IN PROSTACYCLIN PRODUCTION IN AORTIC TISSUE - DEPENDENCE ON CORTICOSTERONE

      Life sciences
    76. YOSHIDA Y; SATO Y; OKAMOTO S; SATO F
      AN EFFICIENT APPROACH TO OPTICALLY-ACTIVE BENZOPROSTACYCLINS BY A 2-COMPONENT COUPLING PROCESS

      Journal of the Chemical Society, Chemical Communications
    77. PAVLOVIC M; PETKOVIC D; CVETKOVIC M; MACUT DJ; ZDJELAR K; NESIC M; BOSNIC O; RADULOVIC R; MIHAIJOVIC M
      THE INFLUENCE OF PROSTACYCLIN (PGI(2)) ON CONTRACTILE PROPERTIES OF ISOLATED RIGHT VENTRICLE OF RAT-HEART

      Experientia
    78. MATSUMURA Y; ASAI T; SHIMADA T; NAKAYAMA T; URUSHIHARA M; MORIZAWA Y; YASUDA A; YAMAMOTO T; FUJITANI B; HOSOKI K
      NOVEL FLUOROPROSTACYCLIN ANALOGS WITH MODIFIED CYCLOALKYLENYL CHAINS - HIGHLY POTENT AND ORALLY-ACTIVE ANTIANGINAL AGENTS

      Chemical and Pharmaceutical Bulletin
    79. TANAKA M; KOJIMA C; MURAMATSU M; TANABE H
      BINDING AFFINITIES OF ISOCARBACYCLIN METHYL-ESTER AND ITS FREE ACID TO PROSTANOID RECEPTORS

      Arzneimittel-Forschung
    80. INOUE K; AOKI Y; HAYASHI M; KITAHARA S; TANABE H; KIYOKI M; ARAKI H
      EX-VIVO ANTIPLATETLET EFFECTS OF ISOCARBACYCLIN METHYL-ESTER INCORPORATED IN LIPID MICROSPHERES IN RABBITS

      Arzneimittel-Forschung
    81. SINGH HP; COLEMAN ET; HARGROVE M; BARROW SE; MURPHY MB; AHERNE T
      PROSTACYCLIN AND THROMBOXANE LEVELS IN PLEURAL SPACE FLUID DURING CARDIOPULMONARY BYPASS

      The Annals of thoracic surgery
    82. SUETA CA; GHEORGHIADE M; ADAMS KF; BOURGE RC; MURALI S; URETSKY BF; PRITZKER MR; MCGOON MD; BUTMAN SM; GROSSMAN SH; CROW JW; SHAFFER CL; THORN MD
      SAFETY AND EFFICACY OF EPOPROSTENOL IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE

      The American journal of cardiology
    83. PARRATT JR; SZEKERES L
      DELAYED PROTECTION OF THE HEART AGAINST ISCHEMIA

      Trends in pharmacological sciences
    84. VANE JR
      THE CROONIAN LECTURE, 1993 - THE ENDOTHELIUM - MAESTRO OF THE BLOOD-CIRCULATION

      Philosophical transactions-Royal Society of London. Biological sciences
    85. LEGUEN E; MOREL D; LAZOU B; CAMBAR J; POTAUX L
      EFFECT OF CYCLOSPORINE AND THE PROSTACYCLIN ANALOG ILOPROST ON HUMAN GLOMERULAR VASOREACTIVITY

      Nephrology, dialysis, transplantation
    86. UENO Y; MIYAUCHI Y; NISHIO S
      BERAPROST SODIUM PROTECTS OCCLUSION REPERFUSION INJURY IN THE DOG BY INHIBITION OF NEUTROPHIL MIGRATION/

      General pharmacology
    87. PETERSEN JS; DIBONA GF
      FUROSEMIDE ELICITS NONUNIFORM REFLEX RESPONSES VIA CARDIAC SYMPATHETIC AFFERENTS

      Hypertension
    88. JEN CJ; HUANG TY; CHEN HI; WING LYC; LIN MT; WU HL; CHANG WC
      REGIONAL DIFFERENCES IN PROSTAGLANDIN PRODUCTION-RATES AMONG PORCINE INTRATHORACIC VESSELS

      Prostaglandins
    89. YUKI H; SATO S; ARISAKA Y; KATO S; TOMOIKE H
      ORALLY-ADMINISTERED BERAPROST SODIUM INHIBITS PULMONARY-HYPERTENSION INDUCED BY MONOCROTALINE IN RATS

      Tohoku Journal of Experimental Medicine
    90. MYERS SI; EVANS CT; HERNANDEZ R; BARTULA L
      INCREASED SPLANCHNIC PROSTACYCLIN SYNTHASE AND CYCLOOXYGENASE CONTENTAND ACTIVITY DURING ISCHEMIA IS DUE TO NEW-PROTEIN SYNTHESIS

      Surgery
    91. LHOTAK P; PALECEK J
      3 COMPONENT SYNTHESIS OF PROSTANOIDS - TH E USAGE OF ALDEHYDES, NITROOLEFINS AND DERIVATIVES OF CARBOXYLIC-ACIDS IN TANDEM ADDITION

      Chemicke listy
    92. KAWAI Y; OHHASHI T
      EFFECTS OF ISOCARBACYCLIN, A STABLE PROSTACYCLIN ANALOG, ON MONKEY ISOLATED CEREBRAL AND PERIPHERAL ARTERIES

      British Journal of Pharmacology
    93. WODITSCH I; SCHROR K
      REDUCED ENDOTHELIUM-DEPENDENT RELAXATION AT ENHANCED NO RELEASE IN HEARTS OF HYPERCHOLESTEROLEMIC RABBITS

      British Journal of Pharmacology
    94. GERSHLICK AH; SPRIGGINS D; DAVIES SW; COURT YDS; TIMMINS J; TIMMIS AD; ROTHMAN MT; LAYTON C; BALCON R
      FAILURE OF EPOPROSTENOL (PROSTACYCLIN, PGI(2)) TO INHIBIT PLATELET-AGGREGATION AND TO PREVENT RESTENOSIS AFTER CORONARY ANGIOPLASTY - RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL

      British Heart Journal
    95. WILLIAMS SP; DORN GW; RAPOPORT RM
      PROSTAGLANDIN I-2 MEDIATES CONTRACTION AND RELAXATION OF VASCULAR SMOOTH-MUSCLE

      The American journal of physiology
    96. KATSUBE N; SAKAGUCHI K; FUJITANI B; AISHITA H
      ANTIPLATETLET AND ANTITHROMBOTIC EFFECTS OF OP-41483-CENTER-DOT-ALPHA-CD, A PROSTACYCLIN ANALOG, IN EXPERIMENTAL-ANIMALS

      Prostaglandins, leukotrienes and essential fatty acids
    97. KINOSHITA M; IWASAKI H; YASOSHIMA A; TAMAKI H
      EFFECTS OF ECABET SODIUM (TA-2711), A NEW ANTIULCER AGENT, ON GASTROINTESTINAL MUCOSAL PROSTANOID PRODUCTION AND MORPHOLOGY IN RATS

      Biological & pharmaceutical bulletin
    98. RUSSELL P; WRIGHT C; KAPELLER K; BARER G; HOWARD P
      ATTENUATION OF CHRONIC HYPOXIC PULMONARY-HYPERTENSION IN RATS BY CYCLOOXYGENASE PRODUCTS AND BY NITRIC-OXIDE

      The European respiratory journal
    99. KOBZAR G; MARDLA V; JARVING I; LOHMUS M; VAHEMETS A; SAMEL N; LILLE U
      COMPARISON OF THE INHIBITORY EFFECT OF E-PROSTAGLANDINS IN HUMAN AND RABBIT PLATELET-RICH PLASMA AND WASHED PLATELETS

      Comparative biochemistry and physiology. C. Comparative pharmacologyand toxicology
    100. CORSI M; PARISE M; GAJA G; FERRERO ME
      ANTIISCHEMIC EFFECT OF DEFIBROTIDE TREATMENT IN RAT-KIDNEY

      Drugs under experimental and clinical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 13:39:46